Your search history is turned on.
Date: February 20, 2024 Jurisdictions: Alberta, British Columbia, Ontario
1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Mathew Lee, Chief Financial Officer of Lobe Sciences Ltd., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Lobe Sciences Ltd. (the issuer) for the interim period ended November 30, 2023...
_ 1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Philip J. Young, Chief Executive Officer of Lobe Sciences Ltd., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of Lobe Sciences Ltd. (the issuer) for the interim period ended November...
LOBE SCIENCES LTD. Managements Discussion & Analysis For the three months ended November 30, 2023 and 2022 (Expressed in Canadian dollars) LOBE SCIENCES LTD. Managements Discussion & Analysis For the three months ended November 30, 2023 and 2022 (Expressed in Canadian dollars, except where noted) ...
Greenstone - Financial Statements - Prelim (01549002.DOCX;2) LOBE SCIENCES LTD. Condensed Interim Consolidated Financial Statements For the three months ended November 30, 2023 and 2022 (Unaudited - Expressed in Canadian dollars) Notice of Disclosure of Non-audit...
Date: February 15, 2024 Jurisdictions: Alberta, British Columbia, Ontario
FORM 52-109FV1 CERTIFICATION OF ANNUAL FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Mathew Lee, Chief Financial Officer of Lobe Sciences Ltd. certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by reference in the AIF (togeth...
FORM 52-109FV1 CERTIFICATION OF ANNUAL FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Philip J. Young, Chief Executive Officer of Lobe Sciences Ltd., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by reference in the AIF (...
LOBE SCIENCES LTD. Managements Discussion & Analysis For the years ended August 31, 2023 and 2022 (Expressed in Canadian dollars) LOBE SCIENCES LTD. Managements Discussion & Analysis For the years ended August 31, 2023 and 2022 (Expressed in Canadian dollars, except where noted) 1 MANAG...
Greenstone - Financial Statements - Prelim (01549002.DOCX;2) LOBE SCIENCES LTD. Consolidated Financial Statements For the years ended August 31, 2023 and 2022 (Expressed in Canadian dollars) INDEPENDENT AUDITORS REPORT To the Shareholders of Lobe Sciences Ltd. Opinion We have a...
Date: January 15, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Press Release Lobe Sciences Provides Default Status Update for Voluntary MCTO January 15, 2024 -- Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) ("Lobe" or the "Company"), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases, is providing a default status report in accordance with the alternative info...
Date: January 2, 2024 Jurisdictions: Alberta, British Columbia, Ontario
LEGAL*57115339.3 Press Release Lobe Sciences Announces Application for Voluntary MCTO December xx, 2023 -- Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) ("Lobe" or the "Company"), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases today announces that it has proactively applied for a voluntary ma...